Richard P Slaughter Associates Inc Buys 762 Shares of UnitedHealth Group Incorporated $UNH

Richard P Slaughter Associates Inc boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 37.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,824 shares of the healthcare conglomerate’s stock after purchasing an additional 762 shares during the quarter. Richard P Slaughter Associates Inc’s holdings in UnitedHealth Group were worth $881,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of UNH. Brighton Jones LLC increased its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the period. Tang Capital Management LLC increased its position in UnitedHealth Group by 62.3% during the 4th quarter. Tang Capital Management LLC now owns 2,308 shares of the healthcare conglomerate’s stock worth $1,168,000 after buying an additional 886 shares during the period. Strive Asset Management LLC bought a new position in UnitedHealth Group during the 4th quarter worth $404,000. Finally, Strategic Wealth Partners Ltd. grew its holdings in shares of UnitedHealth Group by 108.2% during the 4th quarter. Strategic Wealth Partners Ltd. now owns 13,202 shares of the healthcare conglomerate’s stock worth $7,013,000 after purchasing an additional 6,860 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

Shares of UnitedHealth Group stock opened at $352.61 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a 50 day moving average price of $291.98 and a two-hundred day moving average price of $368.31. The stock has a market capitalization of $319.35 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 2.30 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business posted $6.80 EPS. The company’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. KeyCorp reduced their price objective on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Robert W. Baird reissued an “underperform” rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Truist Financial lifted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, Oppenheimer cut their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.